Ex vivo assays performed on tumor cell cultures exposed to a TKI for two hours from a single patient case with IS, demonstrated a dose-response in decreasing PDGFRA phosphorylation confirmed by western blotting [2]. The gene discussed is PDGFRA; the disease is neoplasm.